Chemo brain - a psychotropic drug phenomenon?

Area of Science:

• Neuroscience
• Oncology
• Pharmacology

Background:

• Chemo brain, a cognitive impairment, is an acknowledged side effect of cancer therapies.
• Psychiatric drugs show potential in cancer treatment by influencing gene expression and cell death.
• The mechanisms underlying these drugs' anti-cancer effects may also harm healthy neurons.

Purpose of the Study:

• To hypothesize that psychopharmaceuticals used in cancer treatment can induce chemo brain.
• To explore the potential neurotoxic effects of psychiatric drugs on non-diseased neurons.
• To encourage clinicians to consider psychotropic chemo brain when prescribing medications.

Main Methods:

• Review of preliminary research on psychopharmaceuticals in oncology.
• Hypothetical model linking drug mechanisms to neurotoxicity.
• Discussion of specific drug examples and their oncological applications.

Main Results:

• Valproic acid, clomipramine, and fluoxetine are discussed as examples.
• These drugs, used for various cancers, may induce cognitive deficits through shared mechanisms.
• Potential for psychotropic chemo brain exists across different medical specializations.

Conclusions:

• Clinicians should be aware of the risk of psychotropic chemo brain.
• Minimizing exposure to causative agents is recommended.
• Rehabilitative strategies are vital for mitigating or reversing cognitive impairments.